Three things to know:
1. Ossifix develops implants from high-density, allograft cortical bone.
2. Umbra and Ossifix are working to create biodegradable polymer-based surgical instrumentation featuring antimicrobial technology.
3. CEO Alex Umbra said the transaction is part of the company’s “growth through acquisition approach,” which will expand its reach in orthopedics.
More articles on devices:
The most controversial trends in spine from 10 surgeons
6 Texas orthopedic practices to merge into 150-plus physician group
We’re going to need a bigger scalpel — Mississippi spine surgeon operates on sand tiger shark’s spine
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
